First Clinical Experience of Intra-Operative High Intensity Focused Ultrasound in Patients with Colorectal Liver Metastases: A Phase I-IIa Study

Abstract

BackgroundSurgery is the only curative treatment in patients with colorectal liver metastases (CLM), but only 10–20% of patients are eligible. High Intensity Focused Ultrasound (HIFU) technology is of proven value in several indications, notably prostate cancer. Its intra-operative use in patients with CLM has not previously been studied. Preclinical work suggested the safety and feasibility of a new HIFU device capable of ablating volumes of up to 2cm x 2cm in a few seconds.MethodsWe conducted a prospective, single-centre phase I-IIa trial. HIFU was delivered immediately before scheduled hepatectomy. To demonstrate the safety and efficacy of rapidly ablating liver parenchyma, ablations were performed on healthy tissue within the areas scheduled for resection.ResultsIn total, 30 ablations were carried out in 15 patients. These ablations were all generated within 40 seconds and on average measured 27.5mm x 21.0mm. The phase I study (n = 6) showed that use of the HIFU device was feasible and safe and did not damage neighbouring tissue. The phase IIa study (n = 9) showed both that the area of ablation could be precisely targeted on a previously implanted metallic mark (used to represent a major anatomical structure) and that ablations could be undertaken deliberately to avoid such a mark. Ablations were achieved with a precision of 1–2 mm.ConclusionHIFU was feasible, safe and effective in ablating areas of liver scheduled for resection. The next stage is a phase IIb study which will attempt ablation of small metastases with a 5 mm margin, again prior to planned resection.Trial RegistrationClinicalTrials.govNCT01489787

Non‐invasive high‐intensity focused ultrasound treatment of the placenta: a preliminary in‐vivo study using a simian model

“…For this preclinical work, temperatures of the skin and amniotic cavity were verified using thermocouples. Guidance by ultrasound is sufficient to target accurately the region to be treated and evaluate the resulting coagulation. Temperature estimation during treatment will not be used clinically; it is not an absolute requirement if targeting is accurate.…”

An Ultrasound Image-Based Dynamic Fusion Modeling Method for Predicting the Quantitative Impact of In Vivo Liver Motion on Intraoperative HIFU Therapies: Investigations in a Porcine Model

“…The principal interest lies in the possibility of treating hepatic parenchyma in a short period of time (ablation of 5–7 cm 3 in 40 s) without any organ puncture or blood contact. The intraoperative approach selected for the toroidal HIFU treatment (after surgical laparotomy) makes it possible to reach all regions of the liver without penetrating the hepatic capsule, particularly in Human for whom all liver sectors are accessible by this strategy [ 65 ]. This configuration also enables the protection of surrounding organs and eliminates the risk of secondary lesions.…”

Locoregional treatment for hepatocellular carcinoma: The best is yet to come

“…Besides allowing a better staging of malignancies, large areas of liver can be rapidly ablated in an open procedure. In a feasibility study by Dupré et al [60] , this approach was found to be effective in patients with colorectal liver metastases. In 30 ablations performed in 15 patients, intra-operative HIFU was found to be safe, feasible, and without damage to neighboring tissues [60] .…”

“…In a feasibility study by Dupré et al [60] , this approach was found to be effective in patients with colorectal liver metastases. In 30 ablations performed in 15 patients, intra-operative HIFU was found to be safe, feasible, and without damage to neighboring tissues [60] . Recently, Gandini evaluated in an animal model the use of HIFU for assisting liver resection in an open procedure [61] .…”